Every figure this model derived for DBD, the value it took, and
the element in the company's own XBRL it was read from — so any of it can be checked
against the filing rather than taken on trust.
As at 2026-06-30.
The figures, and where each came from
This is the part no other screener shows. Each figure below names the XBRL element it
was read from, so it can be checked against the filing itself.
The figures themselves rather than their scores — what somebody looking up
DBD on one particular measure came for.
Ratio
Value
cash operating margin
9.92
current ratio
1.63
current ratio reported
1.27
deferred revenue growth
-13.38
dilution pct
-1.06
ebit cagr
13.92
ebit yoy
42.04
fcf margin
7.05
interest cover
2.74
net debt ebitda
1.85
operating margin
6.36
owner earnings margin
6.71
revenue growth
5.44
revenue growth per share
6.57
roic
11.75
rpo growth
7.69
rule of 40
11.8
sbc pct revenue
0.34
What to be careful about
What this model itself distrusts about DBD's figures. Written by the
derivation as it ran, not added afterwards.
no current capital expenditure tagged (last tagged 2020-09-30); treated as zero, so free cash flow is overstated and equals operating cash flow
no market cap; set `market_cap` in overrides.yaml
no forward EPS estimate; growth rests on filings only. Analyst consensus is not published in XBRL, so it has to be fetched from a data provider or set by hand in overrides.yaml as `eps_growth_2y`
valuation DROPPED from the total: only 0 of 2 inputs could be computed (ev sales, ev owner earnings not tagged), so the score is not meaningful. Its weight is spread over the other dimensions